Dodecyl Creatine Ester (Ceres Brain Therapeutics)

N/A

Report date: 2025/08/07 20:00:08
NME

Base Information

Drug NameDodecyl Creatine Ester (Ceres Brain Therapeutics)
Drug Alias NameDodecyl creatine ester hydrochloride (Ceres Brain Therapeutics)CBT101 (Ceres Brain Therapeutics)CBT102 (Ceres Brain Therapeutics)
ClassificationSmall molecules
Mechanisms of ActionCreatine replacements
TargetsCreatine kinase
Therapy Area/IndicationsCreatine Deficiency SyndromesDeficiency DiseasesMitochondrial Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCeres Brain Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesCERES BRAIN TherapeuticsCeres Brain Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsCreatine Deficiency SyndromesMitochondrial DiseasesNeurodegenerative Diseases +[4] 
Inactive IndicationsDeficiency Diseases

Other Information

ATC CodeN/A
Related LinksN/A